EVAXION A/S
EVAX · NASDAQ
Updated at 2026-10-13 15:18:11
- Today's High
- $2.99
- Today’s Low
- $2.85
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.07
- Previous Close
- $3.00
- Volume
- 60.82K
- Market Cap
- $25.6M
- P/E Ratio
- --
- EPS
- $-0.01
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- DR. NEERGAARDS VEJ, HORSHOLM, DENMARK, 2970
- Country
- DK
- Listing Date
- 2021-02-05
- Fiscal Year End
- December
- Shares Outstanding
- 417.01M
- CIK
- 0001828253
- Website
- evaxion.ai
Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company is headquartered in Hoersholm, Denmark.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$22.04K
2025-09-30
$7.49M
Operating Expenses
2026-06-30
$3.84M
2026-03-31
$3.81M
2025-12-31
$4.05M
2025-09-30
$4.47M
Net Income
2026-06-30
-$3.72M
2026-03-31
-$3.62M
2025-12-31
-$5.91M
2025-09-30
$4.61M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
-26.85K%
2025-09-30
61.63%
Earnings Per Share
2026-06-30
$-0.50
2026-03-31
$-0.01
2025-12-31
$-0.01
2025-09-30
$0.01
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.84M
2026-03-31
-$3.51M
2025-12-31
-$8.28M
2025-09-30
$5.71M
Effective Tax Rate
2026-06-30
5.18%
2026-03-31
5.61%
2025-12-31
4.14%
2025-09-30
-6.08%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $22.04K | $7.49M |
| Operating Expenses | $3.84M | $3.81M | $4.05M | $4.47M |
| Net Income | -$3.72M | -$3.62M | -$5.91M | $4.61M |
| Net Profit Margin | -- | -- | -26.85K% | 61.63% |
| Earnings Per Share | $-0.50 | $-0.01 | $-0.01 | $0.01 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.84M | -$3.51M | -$8.28M | $5.71M |
| Effective Tax Rate | 5.18% | 5.61% | 4.14% | -6.08% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.